Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
1000 participants
INTERVENTIONAL
2006-05-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nexium Dyspepsia/AST
NCT00251914
Drug Interaction Study Between AZD3355 and Nexium
NCT00684190
Nexium Dyspepsia/AST
NCT00251992
Adult Asthmatics and Acid Reflux
NCT00628953
Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage
NCT00524329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Esomeprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Contraindications to Nexium
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Villy Meineche Schmidt, MD
Role: PRINCIPAL_INVESTIGATOR
Charlottenlund Research Site
Stig Waldorff, MD
Role: STUDY_DIRECTOR
AstraZeneca, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aabenraa, , Denmark
Research Site
Aalborg, , Denmark
Research Site
Albek, , Denmark
Research Site
Ans, , Denmark
Research Site
Arhus C, , Denmark
Research Site
Bagsværd, , Denmark
Research Site
Birkerød, , Denmark
Research Site
Brønshøj, , Denmark
Research Site
Farum, , Denmark
Research Site
Fredericia, , Denmark
Research Site
Frederikshavn, , Denmark
Research Site
Frederikssund, , Denmark
Research Site
Gråsten, , Denmark
Research Site
Haslev, , Denmark
Research Site
Herning, , Denmark
Research Site
Hinnerup, , Denmark
Research Site
Karlslunde, , Denmark
Research Site
Kerteminde, , Denmark
Research Site
Kobenhavn K, , Denmark
Research Site
Kolding, , Denmark
Research Site
Løsning, , Denmark
Research Site
Middelfart, , Denmark
Research Site
Næstved, , Denmark
Research Site
Odense C, , Denmark
Research Site
Randers, , Denmark
Research Site
Roskilde, , Denmark
Research Site
Rungsted Kyst, , Denmark
Research Site
Rødovre Municipality, , Denmark
Research Site
Saltum, , Denmark
Research Site
SEBY, , Denmark
Research Site
Sindal, , Denmark
Research Site
Solrød Strand, , Denmark
Research Site
Svendborg, , Denmark
Research Site
Tåstrup, , Denmark
Research Site
Tønder, , Denmark
Research Site
Ullerslev, , Denmark
Research Site
Viborg, , Denmark
Research Site
Viby J, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bytzer P, Langkilde LK, Christensen E, Meineche-Schmidt V. Work productivity improvement after acid suppression in patients with uninvestigated dyspepsia. Dan Med J. 2012 Jul;59(7):A4461.
Meineche-Schmidt V, Christensen E, Bytzer P. Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study. Aliment Pharmacol Ther. 2011 Jan;33(1):41-9. doi: 10.1111/j.1365-2036.2010.04501.x. Epub 2010 Oct 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RESPONSE
Identifier Type: -
Identifier Source: secondary_id
D9612L00076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.